
New or enlarging white patches require a different treatment strategy from vitiligo that has remained unchanged. By identifying disease activity, confirming the diagnosis, and matching treatment to lesion size, location, age, and affected skin area, you can understand which options are realistic and when surgery should be considered.
Key takeaways
- New patches, spreading edges, or Koebner lesions indicate active vitiligo.
- A dermatologist confirms vitiligo and checks similar conditions with examination and targeted tests.
- Active vitiligo usually needs disease control before repigmentation treatment.
- Surgery suits carefully selected patients with stable, treatment-resistant vitiligo.
How do you know whether vitiligo is active or stable?
A dermatologist classifies vitiligo by combining your timeline with a skin examination, not by judging whether patches look unchanged at one visit. Active vitiligo means new lesions, enlarging patches, or fresh depigmentation after friction, scratching, burns, or pressure—the Koebner phenomenon.
- Ask yourself when each patch first appeared, whether its edge has expanded, and whether any new spot developed during the past six months.
- Bring older photographs if you have them; they help reveal slow enlargement that is easy to miss.
- During examination, the dermatologist maps lesion borders, checks typical sites and body symmetry, looks for faint new areas with a Wood lamp, and inspects friction-prone skin for Koebner lesions.
- The clinician also records segmental versus nonsegmental distribution, hair whitening within patches, treatment changes, and symptoms or triggers such as injury, illness, or new medicines.
| Finding | What it indicates | Treatment implication |
|---|---|---|
| Active vitiligo | New lesions, enlarging patches, or Koebner phenomenon within the recent history | Prioritise disease control; grafting is usually deferred |
| Stable vitiligo | No new lesions, enlargement, or Koebner phenomenon for at least 6 months | Consider repigmentation choices after individual assessment |
| Uncertain vitiligo stability | The history is unclear, photographs are unavailable, or subtle progression appears on examination | Monitor with dated photographs before selecting an irreversible procedure |
Vitiligo stability is often documented for six months; surgical protocols frequently prefer 12 months because ongoing activity can cause pigment loss or new untreated patches.
How is vitiligo confirmed and separated from similar white patches?
Vitiligo diagnosis starts with an examination of acquired, sharply defined depigmented patches. A dermatologist checks the skin, hair, lips, and mucosa, then asks when the patches appeared, whether they are spreading, and whether injury, inflammation, chemicals, medicines, or autoimmune disease preceded them.
A Wood’s lamp examination makes vitiligo look bright blue-white and exposes lesions that are difficult to see in room light.
| Condition | Findings that separate it from vitiligo | Useful confirmation |
|---|---|---|
| Tinea versicolor | Fine scale, mild itch, and patches on the trunk; pigment can be lighter or darker rather than completely absent | Skin scraping with potassium hydroxide (KOH) can show yeast and short hyphae |
| Pityriasis alba | Ill-defined pale facial patches with dryness or fine scale, usually in children | Clinical examination; pigment is reduced, not fully lost |
| Post-inflammatory hypopigmentation | A clear history of eczema, psoriasis, infection, injury, or a previous rash at the same site | The preceding inflammation and gradual colour return support the diagnosis |
| Chemical leukoderma | Sharply depigmented areas matching contact with hair dye, rubber, adhesives, or industrial chemicals | Exposure pattern and timing; stop the suspected chemical |
| Nevus depigmentosus | Present from birth or early childhood, usually a stable, localized patch | Long-term stability and examination distinguish it from acquired vitiligo |
If the appearance remains uncertain, dermoscopy or a skin biopsy can exclude other disorders. A diagnosis also requires checking for more than one cause, because vitiligo and post-inflammatory or chemical pigment loss can occur together.
Which treatments are used for active vitiligo?
New or enlarging patches need an active vitiligo treatment plan aimed at stopping spread and restoring pigment. The choice depends on body site, extent, speed of progression, age, and treatment risks.
| Option | Best fit | Important limitation |
|---|---|---|
| Topical corticosteroids | Localized patches on trunk or limbs | Prolonged use can cause atrophy, stretch marks, and visible small blood vessels |
| Tacrolimus or pimecrolimus | Face, eyelids, and skin folds | Tacrolimus for vitiligo is generally off-label; early burning or stinging is common |
| Ruxolitinib cream | Appropriate nonsegmental vitiligo cases meeting prescribing criteria | Use requires clinician assessment and monitoring |
| Narrowband UVB phototherapy | Widespread nonsegmental disease | Usually requires two or three sessions weekly for many months; fingers, toes, and lips respond less reliably |
| Targeted phototherapy or 308-nm excimer treatment | Smaller or resistant patches | Repeated clinic sessions and careful dose adjustment are needed |
Topical corticosteroids can repigment active lesions, but the face and folds need shorter or intermittent regimens. Narrowband UVB phototherapy treats larger areas, while targeted light or excimer treatment limits exposure to selected patches.
Ask a dermatologist to look for friction, burns, cuts, chemical exposure, or pressure that could trigger new lesions, and to assess associated autoimmune disease such as thyroid disease. Rapidly spreading vitiligo may prompt specialist-directed systemic corticosteroid mini-pulses.
These suppress new lesion formation rather than reliably restoring pigment and can affect weight, blood pressure, glucose, mood, infection risk, and bone health, so never self-treat with them.
How do treatment choices change for stable vitiligo?
Stability widens the choice of stable vitiligo treatment, but it does not guarantee repigmentation. Your dermatologist weighs lesion size, body location, age, and total affected body surface area before selecting concealment, light treatment, or a procedure.
| Option | Best fit | Important limits |
|---|---|---|
| Camouflage makeup | Small or visible patches when you need an immediate result | Conceals contrast but does not restore melanocytes or change disease activity |
| Skin dyes | Longer-wearing colour on exposed, localized areas | Requires careful colour matching and repeated application as it fades |
| Sunscreen | Every depigmented area, especially areas exposed to sunlight | Prevents burns; tanning surrounding skin can make patches look whiter |
| Self-tanning products | Temporary blending over larger areas | Colours the surface only and can look uneven on dry or thick skin |
| Medical tattooing | Small, stable patches such as selected lip or facial areas | Colour can mismatch, fade, or change; it is unsuitable for many active or sensitive sites |
| Repigmentation treatment | Localized or widespread stable patches when restoring pigment is the goal | Results vary by site, age, treatment duration, and remaining pigment cells |
| Narrowband UVB | Widespread nonsegmental disease | Usually requires two or three sessions weekly for many months; face and trunk respond better than fingers, toes, and lips |
| 308-nm excimer laser | Small, localized patches where normal skin should receive less exposure | It cannot reliably repigment acral or mucosal lesions and does not replace disease stabilization |
Children and adults may need different tolerability and practicality decisions. Narrowband UVB suits extensive involvement, while excimer laser treatment suits limited disease; camouflage makeup or sunscreen often makes more sense for a small, highly visible patch. Stable lesions that resist medical treatment can be assessed for grafting separately.
When is surgery appropriate, and what should you ask before choosing it?
Surgery is appropriate for localized, treatment-resistant vitiligo only after established stability: no new patches, enlargement, or Koebner phenomenon for at least six months, with many surgeons preferring 12 months. Active disease makes transferred pigment less predictable because it does not stop vitiligo elsewhere or protect the treated area from future loss.
| Option | How it is performed | Main trade-off |
|---|---|---|
| Punch grafting | Small skin plugs move into depigmented spots | Simple for small areas, but raised grafts, cobblestoning, irregular pigment, and colour mismatch can occur |
| Suction-blister graft | A blister roof from donor skin covers the recipient area | Less scarring, but graft failure, milia, infection, and donor-site discomfort remain possible |
| Split-thickness graft | A thin skin layer covers a larger patch | Wider coverage, with greater risks of scarring, texture change, colour mismatch, and donor-site problems |
| Melanocyte-keratinocyte cell suspension | Cells harvested from donor skin are prepared and spread over the recipient area | Covers larger or irregular areas without a solid graft, but repigmentation can be uneven, incomplete, or lost |
Ask which technique fits the patch’s size, site, skin texture, and donor area; what stability evidence the surgeon requires; and how they manage infection, poor wound healing, graft failure, scarring, milia, or cobblestoning. Ask how often repigmentation fades and what revision would involve.
Khatri Clinic - Best Clinic in Camp 08048047677 can help assess whether disease stability and wound-healing factors make vitiligo surgery a sensible choice.
Related service
Laser Treatment Looking for a trusted Laser Treatment Specialist in Pune for safe, effective, and advanced skin procedures? Our clinic offers US-FDA approved laser... View service → |
Frequently asked questions
How do you know whether vitiligo is active or stable?
Active vitiligo involves new lesions, enlarging patches, or fresh depigmentation after friction, scratching, burns, or pressure. Stable vitiligo shows no new or expanding patches over the dermatologist’s assessed observation period.
How is vitiligo confirmed and separated from similar white patches?
A dermatologist combines your history with a skin examination. A Wood’s lamp examination, dermoscopy, or selected blood tests can help distinguish vitiligo from fungal infection, post-inflammatory hypopigmentation, chemical leukoderma, and other causes.
Which treatments are used for active vitiligo?
Treatment can include topical corticosteroids, topical calcineurin inhibitors, narrowband UVB phototherapy, and other specialist-directed options. The plan depends on body site, extent, age, and disease activity.
How do treatment choices change for stable vitiligo?
Stable vitiligo can be treated with repigmentation methods or, for selected resistant areas, melanocyte or skin-grafting procedures. Your dermatologist will assess stability, patch location, and previous treatment response.
When is surgery appropriate for vitiligo?
Surgery is considered when vitiligo is stable, patches have not recently spread, medical treatment has failed or is unsuitable, and the affected skin has enough healthy donor tissue. Ask about technique, scarring, pigment matching, recovery, and recurrence risk.







